Pharmacological interventions for increasing SIRT1 activity have been reported to delay aging, and associated disorders such as obesity, inflammation, cancer, autoimmune, neurodegenerative, metabolic, and cardiovascular diseases [103,104]. The gene discussed is SIRT1; the disease is cardiovascular disorder.